| Period Ending | 31-Mar-2013 | 31-Dec-2012 | 30-Sep-2012 | 30-Jun-2012 |
|---|
|
Total Revenue
|
1,585,009
|
1,488,385
|
1,601,558
|
1,562,849
| | Cost of Revenue | 786,346 | 738,001 | 796,065 | 782,988 | | |
Gross Profit
|
798,663
|
750,384
|
805,493
|
779,861
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 547,579 | 527,413 | 542,175 | 536,258 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
251,084
|
222,971
|
263,318
|
243,603
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 945 | 1,184 | 1,115 | 607 |
|
Earnings Before Interest And Taxes | 252,029 | 224,155 | 264,433 | 244,210 |
|
Interest Expense | 11,400 | 11,478 | 10,451 | 9,140 |
|
Income Before Tax | 240,629 | 212,677 | 253,982 | 235,070 |
|
Income Tax Expense | 86,300 | 79,875 | 94,650 | 88,950 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 154,329 | 132,802 | 159,332 | 146,120 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
154,329
|
132,802
|
159,332
|
146,120
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
154,329
|
132,802
|
159,332
|
146,120
|
|